Sodium enoxaparin for treatment of immune-mediated sensorineural hearing loss (imsnhl)
The literature does not report others therapeutic protocols for immune-mediated sensorineural hearing loss (IMSNHL) treatment with sodium enoxaparin or other kinds of unfractionated heparin: our decision to use enoxaparin was based both on the pathogenesis of this condition and on evaluation of the other classes of drugs currently used. Fifty patients, who had suffered from […]